Lv1
34 积分 2021-12-11 加入
Ginsenoside Rg5 ameliorates lung inflammation in mice by inhibiting the binding of LPS to toll-like receptor-4 on macrophages
2天前
已完结
Ginsenoside Rg5: A Review of Anticancer and Neuroprotection with Network Pharmacology Approach
2天前
已完结
Body components at T12/L3 on CT and correlation with survival in esophageal cancer
28天前
已完结
Effectiveness of Immune Checkpoint Inhibitors in Patients With Advanced Esophageal Squamous Cell Carcinoma
2个月前
已完结
Safety and antitumour activity of cadonilimab, an anti-PD-1/CTLA-4 bispecific antibody, for patients with advanced solid tumours (COMPASSION-03): a multicentre, open-label, phase 1b/2 trial
2个月前
已完结
Management of Brain Metastases in Tyrosine Kinase Inhibitor–Naïve Epidermal Growth Factor Receptor–Mutant Non–Small-Cell Lung Cancer: A Retrospective Multi-Institutional Analysis
2个月前
已完结
Tiragolumab plus atezolizumab and chemotherapy as first-line treatment for patients with unresectable oesophageal squamous cell carcinoma (SKYSCRAPER-08): a randomised, double-blind, placebo-controlled, phase 3 trial
2个月前
已完结
Efficacy and safety of camrelizumab plus apatinib in patients with advanced esophageal squamous cell carcinoma previously treated with immune checkpoint inhibitors (CAP 02 Re-challenge): A single-arm, phase II study
2个月前
已完结
Rechallenge with immune checkpoint inhibitors for advanced esophageal squamous cell carcinoma
2个月前
已完结
Clinical outcomes for neoadjuvant immunochemotherapy or chemotherapy versus concurrent chemoradiotherapy in limited‐stage small‐cell lung cancer: A retrospective, multi‐center, real‐world study
6个月前
已完结
皖公网安备34019202002308
